XOMA Royalty (XOMA) Operating Margin (2011 - 2026)

XOMA Royalty's (XOMA) quarterly Operating Margin came in at 3.9% in Q1 2026, down 15212.0% year-on-year from N/an in Q1 2025, and up 33.69% quarter-over-quarter from 5.88% in Q4 2025.

XOMA Royalty (XOMA) Operating Margin (2011 - 2026) Analysis & Trends

XOMA Royalty has disclosed Operating Margin across 16 years of filings, most recently posting 3.9% for Q1 2026.

  • Operating Margin for Q1 2026 came in at 3.9%, down 15212.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.45% (up 28362.0% YoY), and the FY2025 annual result was 12.81%, up 15314.0% from the prior year.
  • Operating Margin came in at 3.9% for Q1 2026 at XOMA Royalty, up from 5.88% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 148.22% in Q1 2025 to a low of 62560.0% in Q3 2024.
  • The 5-year median for Operating Margin is 484.94% (2022), against an average of 4232.87%.
  • Across the five-year window, Operating Margin sank 6186277 bps in 2024 and jumped 6196889 bps in 2025, its largest moves.
  • XOMA Royalty's Operating Margin stood at 417.9% in 2022, then sank by 160 bps to 1087.51% in 2023, then sank by 33 bps to 1450.6% in 2024, then surged by 100 bps to 5.88% in 2025, then jumped by 34 bps to 3.9% in 2026.
  • The last three Operating Margin figures came in at 3.9% (Q1 2026), 5.88% (Q4 2025), and 591.11% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -6.43%
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 38.10%
9 Abivax 95.45 Bn 95.45 Bn - -
10 XOMA Royalty 5.52 Mn -60.56 Mn - -3.90%

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.90%
Dec 31, 2025 -5.88%
Sep 30, 2025 -591.11%
Jun 30, 2025 91.60%
Mar 31, 2025 148.23%
Dec 31, 2024 -1,450.60%
Sep 30, 2024 -62,560.00%
Jun 30, 2024 -200.58%
Mar 31, 2024 -470.07%
Dec 31, 2023 -1,087.51%
Sep 30, 2023 -697.23%
Jun 30, 2023 -865.84%
Mar 31, 2023 -2,327.23%
Dec 31, 2022 -417.90%
Sep 30, 2022 -969.40%
Jun 30, 2022 -484.94%
Mar 31, 2022 -66.46%
Dec 31, 2021 15,182.50%
Sep 30, 2021 -355.85%
Jun 30, 2021 -340.07%